JRSIS Health Care Corporation (OTCQX: JRSS) opened a new COVID-19 testing laboratory


HEILONGJIANG PROVINCE, P.R. CHINA, May 7, 2020 - JRSIS Health Care Corporation. ("JRSS" or "the Company") (OTCQX: JRSS)a Florida corporation that owns and operates a network of three hospitals in Harbin City, China, today announced that since May 2020, JRSS opened a new Coronavirus Disease 2019 (COVID-19) testing laboratory in Heilongjiang Province in order to aid the fight against the COVID-19.

Since May 2020, JRSS has established the detection of novel coronavirus PCR laboratory to do COVID-19 testing services. The detection of novel coronavirus PCR laboratory is located at Jiarun Hospital, a subsidiary of JRSIS Health Care Corporation. JRSS will prioritize tests for individuals that are among the highest risk population. JRSS can do COVID-19 testing for 100 people per day.

“From COVID-19 testing, we can collect the test results but also collect the information that we need to come up with policies to beat the virus. " Mr. Zhang Junsheng, Chairman of JRSIS Health Care Corporation, said.

About Jrsis Health Care Corporation.

JRSIS Health Care Corporation provides well rounded medical services to all of its patients. From less complicated services such as Dentistry to highly sophisticated Surgery, the Hospital provides services throughout the 24 hours of the day. Its hospitals boast modern facilities and cutting-edge equipment, as well as highly skilled and experienced personnel ready to attend to patient medical and healthcare needs.

For further information, please visit www.jhcc.cn

Forward-Looking Statements

Certain statements in this news release contain forward-looking information. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. The economic, competitive, governmental, technological and other risk factors identified in the Company's filings with the Securities and Exchange Commission, specifically Item 1A, "Risk Factors," in the Form 10-K for the year ended December 31,2018, may cause actual results or future events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

For Investor Relations and Communications:

Eden Hall Global Capital Co., Ltd


Email: mary20116688@163.com

Skype: marymary4098

Wechat/Mobile: 0086-13510016379


JRSIS Health Care Corporation